SynVivo

SynVivo develops and commercializes advanced cell-based microfluidic organ-on-chip platforms that provide realistic tissue environments for real-time study of cellular behavior, drug delivery, and drug discovery. Their proprietary technology enables more accurate modeling of human physiology than traditional cell culture methods. The company’s chips are used in precision medicine applications such as oncology—where patient biopsy cells can be used to replicate tumor environments—and in neuroscience/toxicology research. Products like the Cancer Chip allow rapid assessment of therapeutic options tailored to individual patients.